TrumpRx Expands Discount Drug Access With 600 Generic Medications 
3 clinical-grade skincare creams you really shouldn’t buy online 
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern 
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough 
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak 
FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise 
Abdul El-Sayed Wins Michigan Democratic Senate Primary, Sets Up Key Midterm Showdown 
Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies 
US Embassies Urge Americans to Leave Middle East as Iran Tensions Escalate 
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal 
Joe Biden’s Prostate Cancer Has Spread Further, Hunter Biden Says 
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations 
US Expands Social Media Vetting to Foreign Journalists Seeking Visas 
US Continues Ukraine Patriot Missile Production Talks Despite Trump Doubts 
Trump Administration Weighs Executive Order on Vaccines and Autism Research 
FAA Proposes Inspections for Boeing 737 MAX Passenger Seats Over Installation Concern 
U.S. Health Secretary Robert F. Kennedy Jr. told lawmakers this week that he is open to sharing details about David Geier’s contract with the Department of Health and Human Services (HHS), signaling growing scrutiny over the controversial appointment. During a Senate Finance Committee hearing, Kennedy stated that the contract could be provided to senators before the end of the week, offering what may become the first clear explanation of Geier’s responsibilities within the agency.
David Geier, known for his long-standing anti-vaccine activism, is currently working as a contractor tied to the Centers for Disease Control and Prevention (CDC). According to federal records, he is listed as a senior data analyst within the HHS system. His involvement has raised concerns among lawmakers and public health experts, particularly given his history of promoting debunked claims linking vaccines to autism.
Senator Ben Ray Luján of New Mexico pressed Kennedy on whether the administration would also release the protocols guiding Geier’s work. Kennedy responded that such protocols are not yet in place but promised they would be shared once the vaccine safety review is completed. Kennedy has previously indicated that Geier is leading a review of CDC vaccine data, a move that has sparked debate due to Geier’s controversial background.
Geier’s past actions have added to the concern. He was previously fined in Maryland for practicing medicine without a license and for administering unsafe treatments to children with autism. Critics argue that his involvement in federal health initiatives could undermine public trust in vaccine safety.
The situation highlights ongoing tensions around vaccine policy, public health transparency, and the role of individuals with disputed scientific views in government positions. As pressure builds, the release of Geier’s HHS contract could play a key role in shaping public and political response to the administration’s handling of vaccine-related issues.
